Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Evaluating phase II results of Baxdrostat, an aldosterone synthase inhibitor for hypertension

Published:2023-11-02 Issue:11 Volume:32 Page:985-995
ISSN:1354-3784
Container-title:Expert Opinion on Investigational Drugs
language:en
Short-container-title:Expert Opinion on Investigational Drugs

Author:

Awosika Ayoola¹,Cho Yoonje¹,Bose Ujjal²,Omole Adekunle E.³,Adabanya Uzochukwu⁴

Affiliation:

1. College of Medicine, University of Illinois, Chicago, USA

2. Department of Pharmacology, American University of Antigua, Antigua, Antigua, Barbuda, West Indies

3. Cell Biology and Anatomy, Louisiana State University, New Orleans, Louisiana, USA

4. Department of Anatomy, Edward Via College of Osteopathic Medicine, Monroe, Louisiana, USA

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/13543784.2023.2276755

Reference48 articles.

1. The global epidemiology of hypertension

2. Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013

3. Essential Hypertension and Oxidative Stress: Novel Future Perspectives

4. Effects on Blood Pressure of Reduced Dietary Sodium and the Dietary Approaches to Stop Hypertension (DASH) Diet

5. Effect of Exercise Training on Ambulatory Blood Pressure Among Patients With Resistant Hypertension

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP